Journal Mobile Options
Table of Contents
Vol. 33, No. 8-9, 2010
Issue release date: September 2010
Onkologie 2010;33:420-421
(DOI:10.1159/000318991)
Editorial

Trastuzumab as Single Agent Therapy for HER2-Positive Metastatic Breast Cancer

Rastogi P. · Davidson N.E.
University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

First-Page Preview
Abstract of Editorial

 goto top of outline Author Contacts

Nancy E. Davidson, MD, University of Pittsburgh Cancer Institute and, UPMC Cancer Centers, 5150 Centre Avenue, Suite 500, Pittsburgh, PA 15232, USA, Tel. +1 412 623-3205, Fax -3210, davidsonne@upmc.edu


 goto top of outline Article Information

Published online: July 21, 2010
Number of Print Pages : 2


 goto top of outline Publication Details

Onkologie (International Journal for Cancer Research and Treatment)

Vol. 33, No. 8-9, Year 2010 (Cover Date: September 2010)

Journal Editor: Schmoll H.-J. (Halle/Saale)
ISSN: 0378-584X (Print), eISSN: 1423-0240 (Online)

For additional information: http://www.karger.com/ONK


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.